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a b s t r a c t
Classic phylogenetic and modern population-based clustering methods were used to analyze hepatitis C
virus (HCV) evolution in plasma and to assess viral compartmentalization within peripheral blood
mononuclear cells (PBMCs) in 6 children during 3.2–9.6 yr of follow-up. Population structure analysis of
cloned amplicons encompassing hypervariable region 1 led to the distinction of two evolutionary patterns,
one highly divergent and another one genetically homogeneous. Viral adaptability was reﬂected by co-
evolution of viral communities switching rapidly from one to another in the context of divergence and
stability associated with highly homogeneous communities which were replaced by new ones after long
periods. Additionally, viral compartmentalization of HCV in PBMCs was statistically demonstrated,
suggesting their role as a pool of genetic variability.
Our results support the idea of a community-based structure of HCV viral populations during chronic
infection and highlight a role of the PBMC compartment in the persistence of such structure.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Hepatitis C virus (HCV) produces a chronic liver infection that
may lead to cirrhosis and hepatocellular carcinoma, which are the
main indications for liver transplantation among adult patients in
developed countries (Ghany et al., 2009; HCV Sequence Database).
However, the outcome of HCV infection acquired in childhood is
uncertain, and HCV-associated liver disease shows a milder clinical
course with a slower progression to ﬁbrosis (Mohan et al., 2010).
HCV is a small enveloped 9.6 kb positive stranded RNA virus of
the Flaviviridae family. The viral envelope consists of a lipid bilayer
derived from the host cell in which the two glycoproteins E1 and E2
are anchored as a heterodimer (Op De Beeck et al., 2001). Both
glycoproteins are essential for HCV entry into hepatocytes (Bartosch
and Cosset, 2006). Hypervariable region 1 (HVR1), encompassing the
ﬁrst 27 amino acids at the N-terminal region of E2, is the most
variable region of the HCV genome (Smith, 1999) and it has been
widely used in studies examining intrahost evolutionary dynamics
(Gismondi et al., 2009; Ramachandran et al., 2011; Palmer et al.,
2012; Alfonso et al., 2005; Farci et al., 2012; Jackowiak et al., 2012;
Figlerowicz et al., 2010; Farci et al., 2006; Li et al., 2008). As
previously demonstrated both in vitro and in vivo, HVR1 contains
a linear neutralizing epitope (Shimizu et al., 1996; Farci et al., 1996)
and thus it is subjected to immune selective pressure of the host.
Despite its variability, this region constitutes a basic stretch, inwhich
the positively charged residues occupy speciﬁc positions (Penin
et al., 2001). Accordingly, HVR1 would be implicated in interactions
with negatively charged molecules present on the cellular surface or
on plasma lipoproteins to which HCV associates (Penin et al., 2001;
Bartosch et al., 2005). Indeed, HVR1 has been related to the binding
with the CD81 receptor on the cellular surface (Roccasecca et al.,
2003), and its relevance for functional interaction of E2 with the
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lipoprotein receptor SR-B1 has been demonstrated (Bartosch et al.,
2005, 2003; Bankwitz et al., 2010; Guan et al., 2012).
HCV replicates primarily in the liver, although extrahepatic
localizations including circulating lymphoid cells which form part
of the peripheral blood mononuclear cells (PBMCs) have been
described (Pal et al., 2006; Goutagny et al., 2003; Lerat et al., 1998;
Roque-Afonso et al., 2005; Forton et al., 2004; Wilkinson et al.,
2009; Radkowski et al., 2002). Only selected HCV variants from the
plethora of sequences present in plasma would be able to associate
with these cells, a phenomenon called viral compartmentalization.
Compartmentalized HCV sequences have been demonstrated both
in immunocompromised (Roque-Afonso et al., 2005; Jouvencel
et al., 2006; Blackard et al., 2007) and immunocompetent
(Zehender et al., 1997; Vera-Otarola et al., 2009) individuals, and
in the setting of liver transplantation (Roque-Afonso et al., 2005;
Ramírez et al., 2009; Schramm et al., 2008). Additionally, PBMC-
associated HCV sequences have also been detected after resolution
of HCV infection thus indicating occult infection (Pham et al.,
2004, 2008). However, no reports exist about compartmentaliza-
tion in pediatric patients with HCV infection.
In the infected patient, HCV exists as a mixture of different
but phylogenetically related sequences referred to as quasispe-
cies (Martell et al., 1992). During the course of infection,
dynamic changes in viral population size and composition
occur, thus facilitating viral escape to the host's immune
response and establishment of persistence (Stumpf and Pybus,
2002). Consequently, HCV evolution reﬂects the continuous
adaptation of the virus to the constantly changing selection
pressures in the host's environment. In that sense, compart-
mentalization could be a mechanism contributing to viral
variability, persistence and pathogenesis in the infected host.
In this work, classic phylogenetic and modern population-based
sequence analysis methods were applied to evaluate if previous
observations obtained using samples from adult patients sug-
gesting a community-based structure of viral populations and
HCV compartmentalization within PBMC during chronic infec-
tion also hold true for pediatric patients.
Results
Clinical characterization of chronic infection during follow-up
Six children with chronic HCV infection were included in this
study. Clinical, biochemical and virological features of the patients
studied are shown in Table 1 and Fig. 1. Three patients received
α-IFN treatment during follow-up. Serum ALT levels were normal or
slightly elevated in patients not undergoing treatment (cases 1–3),
whereas they proved moderately to highly elevated in cases 4–6,
rising approximately three times during α-IFN therapy. Viral load in
plasma was continuously elevated in samples from all patients,
whether treated or not.
Regarding pathogenesis, liver biopsies obtained during follow-up
showed predominantly minor liver damage in all patients (Supple-
mentary Table 2). Hepatitis ranged frommild to moderate and ﬁbrosis
was mostly low. Steatosis was higher in treated patients. Besides,
intralobullar lymphoid follicles were observed only in three samples
from different patients. Lastly, all liver samples showed a similar
proportion of infected hepatocytes (11–22%, data not shown). Taken
together, these observations indicate that liver damage in this cohort
is predominantly mild, in accordance to previous reports on pediatric
cohorts (Mohan et al., 2010).
Evolutionary dynamics in plasma
The existence of multiple viral “communities” co-evolving in the
infected host has been suggested recently (Ramachandran et al.,
2011). This idea prompted us to investigate the genetic structure of
HCV populations within infected hosts using a Bayesian analysis of
population structure (BAPS). To this end, an HVR1-encompassing
fragment was ampliﬁed from consecutive plasma samples and
molecular clones were obtained and sequenced (Supplementary
Table 3). The phylogenetic clusters (communities) inferred by BAPS
were superimposed to the corresponding maximum likelihood (ML)
trees describing the phylogenetic relationships between clonal
sequences from each patient (Fig. 2). Both approaches showed
consistent results since most of the communities obtained over-
lapped well supported clades reconstructed by ML. However, BAPS
analysis allowed identiﬁcation of independent populations other-
wise not evident.
Taking the results of both types of analysis together, two levels
of viral evolution were observed within infected hosts. On the one
hand, a small number of viral communities co-evolved throughout
follow-up in all patients, switching intermittently from one to
another (cases 1–4) or being replaced by a new community after a
long period of genetic stability in some cases (cases 5 and 6, see
the communities' frequency plots in Fig. 2). On the other hand, a
more detailed observation of the genetic structure of HCV popula-
tions showed the continuous evolution of viral sequences belong-
ing to each community, probably reﬂecting viral adaptation to
particular environmental conditions within the infected host at
each sampling time point. In this sense, α-IFN treatment did not
abrogate the viral communities present in treated patients neither
during therapy nor after its withdrawal (Fig. 2, cases 4–6),
reﬂecting the existence of “naturally resistant” HCV variants in
them. Most interestingly, the highly homogeneous clusters that
emerged in patients 5 and 6 toward the end of the studied period
formed new viral communities that replaced the pre-existing one;
which until month 26 and 61, respectively, had been the only
community present in each infected child.
Compartmentalization of viral sequences
Viral sequences associated to PBMCs were analyzed in available
samples to study compartmentalization during follow-up. PBMC-
derived HCV RNA was detected in all patients, whereas it was
undetectable in the supernatants of two washing steps performed
during PBMC isolation. Moreover, ampliﬁcation and molecular
cloning of the HVR1-encompassing fragment from plasma and
PBMC samples allowed the identiﬁcation of unique sequences in
each compartment in certain samples, ruling out contamination of
PBMC with plasma-derived sequences.
Both plasma and PBMC samples showed a high number of
variable sites (176/300 and 107/300 sites, respectively) which were
mostly concentrated within the HVR1 region (Fig. 3A and Supple-
mentary Fig. 2), thus demonstrating the heterogeneous character of
the viral quasispecies present in both compartments. Intrasample
HVR1 complexity was lower in PBMCs than in plasma at most
Table 1
Clinical description of the patients included in this study.
Patient
no.
Agea Genderb Route of infection HCV
genotype
Time of follow-
up
1 13 F Transfusion 1a 50 months
2 2 F HCVþ/
HIVþmother
1a 38 months
3 4 M Unknown 1a 51 months
4 11 M Unknown 1a 41 months
5 2 F HCVþ mother 1a 63 months
6 3 M HCVþ mother 1a 115 months
a Age at the beginning of follow-up.
b F stands for female, M for male.
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samples (Fig. 3B), denoting the existence of more homogeneous
variants in PBMCs. Nevertheless, the amino acid proﬁle of this
stretch was similar in both types of samples (Fig. 3C), ruling out the
existence of an amino acid signature related to HCV compartmen-
talization at least within the HVR1 region. Lastly, a deep analysis of
sites subject to selection both in plasma and PBMCs demonstrated a
concentration of positively selected sites within HVR1, particularly
in cases 1–4. Regarding purifying selection, negatively selected sites
predominated outside HVR1 (Supplementary Fig. 2).
As previously reported (Gismondi et al., 2009), almost no HVR1
variability was detected in cases 5 and 6 both in plasma and
PBMCs (data not shown). Noteworthy, in case 6 there was an
increment in complexity around 115 months of follow-up, which
was concurrent with a worsening of the clinical status of this
patient, as perceived in the liver biopsy (Supplementary Table 2).
The detection of different viral sequences in plasma and PBMCs
does not unequivocally demonstrate compartmentalization. Thus,
the overall association between PBMC compartmentalization and
phylogeny was statistically assessed in a Bayesian framework
(BaTS). Both the Association Index (AI) and the Parsimony Score
(PS) showed statistically signiﬁcant differences (po0.001) with
the null distribution (no-association), indicating compartmentali-
zation of PBMC-associated sequences in all cases (Table 2). Of note,
the compartment-speciﬁc Monophyletic Clade (MC) index showed
a signiﬁcant association with PBMCs in all cases, which denotes
compartmentalization of phylogenetically related sequences. This
result was further conﬁrmed by the Slatkin–Maddison test (Slatkin
and Maddison, 1989) (data not shown).
To better characterize PBMC-associated viral variants, their
relation with plasma-derived sequences and their dynamic beha-
vior throughout follow-up in our patients, two types of phyloge-
netic analyses were carried out. The ﬁrst consisted in a maximum
parsimony-based network approach to study the phylogenetic link
between plasma and PBMC-derived sequences. As previously
mentioned by other authors (Ramachandran et al., 2011), this kind
of analysis accurately represents viral evolution, particularly when
using closely related sequences, since this method takes the
phylogenetic uncertainty into account. Nevertheless, phylogeny
was also reconstructed by ML to check whether there is an
inconsistency in the tree topology between both methods. After
the comparative analysis minor differences were found (data not
shown). The second analysis was the above mentioned BAPS,
whose results were superimposed to the corresponding phyloge-
netic networks (Fig. 4). In line with the compartmentalization tests
performed in BaTS, in all patients' networks large clusters of
homogeneous sequences derived from PBMCs were observed,
Fig. 1. Biochemical and virological features of the patients studied. Serum alanine aminotransferase (ALT) levels during follow-up are shown as ﬁlled areas on the left Y axis
and HCV viral load in plasma is shown as black boxes on the right Y axis. Vertical discontinuous lines indicate samples used for phylogenetic analysis in this study. Duration
of α-IFN treatment (cases 4–6) is shown as a black box on top of each plot. Serum ALT levels o32 IU/l were considered as normal.
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which sometimes were very distinct respect to concomitant
plasma sequences, thus explaining the statistically signiﬁcant
results obtained by BaTS. However, in some samples, sequences
from plasma and PBMCs were closely related or even identical
during follow-up. Compartmentalized HCV variants exhibited a
dynamic behavior in consecutive paired plasma-PBMC samples of
each patient, although without showing a clear phylogenetic
association between serial PBMC samples. Together, these results
reveal a continuous genetic ﬂow between both compartments
during chronic infection and suggest some kind of constraint for
lymphotropism imposed to particular viral variants.
As mentioned above, viral sequences present in plasma were
grouped into viral communities that evolved simultaneously in the
infected patient over time. We hypothesized that (a) PBMC-derived
sequences could be partitioned into the previously deﬁned viral
communities observed in plasma samples (Fig. 2) or (b) they could
constitute independent communities associated with the cellular
compartment. The BAPS analysis performed with all sequences from
both compartments showed that in the majority of cases PBMC-
derived sequences did not form plasma-independent communities
(Fig. 4); instead, they were distributed among the previously
identiﬁed viral communities along with sequences present in plasma
concomitantly or not. Besides, one community described in Fig. 2
(Case 2, Com 3) split into two sub-communities containing more
closely related plasma and/or PBMC derived sequences (Com 3A and
Com 3B in Fig. 4), likely due to a more accurate phylogenetic signal
contained in these sequences. Somehow, these homogeneous clus-
ters from PBMCs allowed further partition of this community.
Fig. 2. Evolutionary dynamics of HCV quasispecies in plasma. Maximum-likelihood phylogenetic trees were reconstructed with all plasma-derived nucleotide sequences
from each patient. Colored dots represent clones from different time points. Numbers at tree nodes indicate bootstrap values. The scale bar indicates number of substitutions
(nucleotides/site). Viral communities identiﬁed by BAPS analysis are represented as colored areas and superimposed with the phylogenetic trees for each case. Temporal
variations in the composition of viral communities detected in each patient during follow-up are depicted in graphics under each phylogenetic tree. Colored areas indicate
independent communities. Duration of α-IFN treatment (cases 4–6) is shown as a black box on top of each plot.
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Fig. 3. Complexity of plasma and PBMC-associated viral quasispecies. (A) Variability of the ampliﬁed region at the nucleotide level, as represented by the entropy at each
position in a sequence alignment including all plasma (left) or PBMC (right) sequences from cases 1–6. (B) Intra-sample complexity within HVR1 as calculated by the
normalized Shannon entropy of amino acid sequences. Values obtained for plasma and PBMC samples are represented as black and white symbols, respectively. (C) Sequence
logo representations based on HVR1 amino acid alignments of plasma (top) and PBMC (bottom) derived sequences from cases 1–6. The frequency of each residue at each
position is indicated by the relative height of the corresponding letter, and the overall height of the stack denotes the degree of sequence conservation. Logos were obtained
using WebLogo program (Crooks et al., 2004).
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Interestingly, although PBMC-derived variants were generally asso-
ciated to the same viral communities previously described in plasma,
they did not exactly mimic their dynamics over time (compare
graphics in Figs. 2 and 4). This observation became particularly
striking among treated patients 4 and 6, where viral sequences
present concomitantly in plasma and PBMCs were partitioned into
different communities, reﬂecting the pool character of the cellular
compartment and its contribution to viral diversity.
Discussion
Intrahost evolution of the HVR1 region has been extensively
studied in adult patients with chronic HCV infection (Ramachandran
et al., 2011; Palmer et al., 2012; Alfonso et al., 2005; Farci et al., 2012),
and to a lesser extent in pediatric individuals (Gismondi et al., 2009;
Jackowiak et al., 2012; Figlerowicz et al., 2010; Farci et al., 2006;
Quesnel-Vallieres et al., 2008). However, long-term follow-up studies
in children in the absence of HIV co-infection are scarce. Moreover,
population structure and compartmentalization of HCV quasispecies,
treated here, had never been thoroughly evaluated in children before.
As already mentioned, this novel kind of analysis of viral sequences
more accurately reﬂects viral evolution during chronic infection,
since it takes into account the whole population circulating in
the infected host at any time point and does not found on an
evolutionary model as classic phylogenetic methods assuming bifur-
cating trees do (Farci et al., 2006).
In this study, different evolutionary patterns not clearly
associated neither with α-IFN treatment nor with the route of
transmission were distinguished. Instead, our results illustrate
viral adaptation to a continuously changing environment
within the infected host, probably as a result of the host's
immune selective pressure, as previously seen by other authors
in both pediatric and adult patients (Ramachandran et al.,
2011; Farci et al., 2006, 2012; Rehermann, 2009). Importantly,
we have demonstrated that PBMC compartmentalization of
HCV commonly exists in children and that it plays a signiﬁcant
role as a pool of genetic variability, thus contributing to viral
persistence.
As expected, sequence variability was mostly concentrated
within HVR1 (Hijikata et al., 1991). Interestingly, intrasample
variability was generally lower in PBMCs than in plasma, and
phylogenetic networks showed highly homogeneous clusters of
PBMC-derived sequences, which reﬂect some kind of constraint
for the association of HCV particles with PBMCs. Conﬂicting
results have been reported about HCV infecting PBMCs (Pham
et al., 2008; Durand et al., 2010) or being attached on the surface
of these cells without infection (Marukian et al., 2008; Natarajan
et al., 2010). The close phylogenetic relationship observed
between plasma and PBMC variants indicates that a continuous
genetic ﬂow between these two compartments commonly exists
and therefore suggests that PBMC-derived sequences do not
follow a plasma-independent evolutionary pathway. Instead,
the model of a temporal association of PBMCs with certain
lymphotropic variants better ﬁts our results, since many com-
munities contained at least one homogeneous cluster of PBMC
clones. Furthermore, codon selection analyses showed a very
similar proﬁle between both compartments in all patients, again
suggesting that forces driving evolution are not compartment-
dependent.
Chronically infected children are generally asymptomatic and
usually have mild abnormal ALT levels, with a small proportion of
them showing an aggressive course leading to end-stage hepatic
disease (Bortolotti et al., 2008; Jara et al., 2003; Jonas, 2002). In
accordance, our series displayed predominantly mild liver damage,
with the exception of case 6 who showed a rapid progression of
injury, requiring multiple biopsies during the follow-up and
resulting in severe hepatitis and incomplete cirrhosis. The
Table 2
Results of Bayesian tips-signiﬁcance tests (BaTS).
Statistic Observed mean (95% CI) Null mean (95% CI) Signiﬁcance level
Case 1 AI 1.75 (1.12–2.38) 3.85 (3.28–4.44) o0.01
PS 12.64 (11.00–14.00) 20.68 (18.60–22.37) o0.01
MC (Plasma) 25.03 (25.00–26.00) 5.47 (4.01–7.37) 0.01
MC (PBMC) 5.12 (5.00–6.00) 2.35 (1.86–3.10) 0.01
Case 2 AI 3.45 (2.45–4.44) 6.32 (5.29–7.19) o0.01
PS 27.13 (24.00–30.00) 37.51 (33.41–40.82) o0.01
MC (Plasma) 6.11 (6.00–7.00) 4.17 (3.29–5.10) 0.03
MC (PBMC) 5.26 (4.00–8.00) 3.65 (2.80–4.97) 0.05
Case 3 AI 2.94 (1.98–3.90) 5.61 (4.66–6.30) o0.01
PS 20.56 (17.00–24.00) 31.87 (29.21–33.59) o0.01
MC (Plasma) 20.49 (20.00–24.00) 5.57 (4.44–7.16) 0.01
MC (PBMC) 6.12 (5.00–8.00) 2.74 (2.26–3.25) 0.01
Case 4 AI 1.42 (0.88–1.95) 5.87 (4.97–6.71) o0.01
PS 11.25 (10.00–12.00) 35.35 (31.68–38.68) o0.01
MC (Plasma) 17.51 (12.00–20.00) 3.69 (2.93–5.20) 0.01
MC (PBMC) 12.48 (12.00–15.00) 3.91 (3.11–5.22) 0.01
Case 5 AI 0.73 (0.20–1.30) 3.10 (2.64–3.56) o0.01
PS 6.80 (5.00–9.00) 16.34 (15.05–17.19) o0.01
MC (Plasma) 15.38 (11.00–24.00) 6.84 (5.52–9.22) 0.01
MC (PBMC) 6.46 (4.00–11.00) 1.94 (1.57–2.24) 0.01
Case 6 AI 2.12 (1.30–2.93) 5.94 (5.30–6.47) o0.01
PS 14.45 (12.00–16.00) 33.81 (31.27–35.49) o0.01
MC (Plasma) 13.99 (11.00–23.00) 5.66 (4.52–8.09) 0.01
MC (PBMC) 19.83 (18.00–20.00) 2.81 (2.42–3.42) 0.01
Association Index (AI), Parsimony Score (PS) and Monophyletic Clade (MC) test the global association between a trait and tree topology. The observed mean and its
associated 95% conﬁdence intervals were obtained by analyzing 10,000 trees sampled during the Bayesian phylogenetic reconstruction. The null mean and its associated
conﬁdence intervals were obtained after randomly distributing the traits in the phylogeny (100 replicates). Signiﬁcance level is the p-value for the statistical hypothesis test
for equality between the observed index and that expected under no-association.
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relationship between the clinical course of chronic hepatitis C and
viral evolution has been addressed before in both adult (Li et al.,
2008; Sullivan et al., 2007; Qin et al., 2005) and pediatric patients
(Farci et al., 2006), where a correlation between hepatic injury and
the development of a mono- or oligoclonal viral population during
long-term follow-up has been described, as well as mild or no liver
damage was correlated with a heterogeneous viral quasispecies. In
accordance, in cases 1–4 the slow progression of hepatitis corre-
lated with a complex population structure in which continuous
emergence and/or disappearance of viral communities was
observed over time. Additionally, in these cases a signiﬁcantly
higher positive selection on individual codons within HVR1 was
evident, indicative of strong immunologic pressure on this region,
which is a major target of neutralizing antibodies. Thus, in these
cases the BAPS clusters mostly reﬂect the population structure
imposed by selection. By contrast, in cases 5 and 6, HVR1
invariability was noted during long periods of time as extensively
described elsewhere (Gismondi et al., 2009). Particularly in case 6,
the slow evolutionary rate was associated with a rapid liver
disease progression. Moreover, the abrupt worsening of the
Fig. 4. Phylogenetic analysis of plasma and PBMC-compartmentalized viral sequences. Maximum parsimony-based networks were constructed with all plasma and PBMC
derived nucleotide sequences from each patient. Each node corresponds to a unique sequence, and the diameter of each circle refers to the frequency of that sequence. Colors
within the circles represent clones from different time points as indicated in the panels above each network. Plasma-derived sequences have the same color-code as in Fig. 2.
Viral communities obtained by BAPS present in both compartments are represented as white areas and superimposed to each network. Viral communities are numbered as
in Fig. 2, and have an almost identical composition regarding plasma-derived clones. In case 2, Com 3 has been split in two sub-communities 3A and 3B. Temporal variations
in the composition of viral communities detected in PBMC compartment are depicted in graphics under each network. Colored areas indicate independent communities,
following the same color-code as in Fig. 2. Duration of α-IFN treatment (cases 4–6) is shown as a black box on top of each plot.
M.I. Gismondi et al. / Virology 447 (2013) 187–196 193
patient's clinical status at 115 months correlated with a switch in
the quasispecies community after 5 yr of an almost complete
invariability in the HVR1 amino acid sequence. Strikingly, at the
same time point, a pronounced compartmentalization of the viral
populations was observed which led to the segregation of a new
PBMC-exclusive community not previously detected during
follow-up.
Additional evidence about the role of PBMC compartmentaliza-
tion in viral persistence can be inferred from case 4, in which an
effect of α-IFN treatment on viral quasispecies was observed.
Quasispecies complexity in plasma decreased during treatment
and simultaneously the main viral community in plasma (Fig. 2,
Com1) declined its dominance while other minor communities
grew. After treatment withdrawal, Com1 predominated again and
ﬁnally, at the late chronic phase, a diversiﬁcation pattern was
observed. Interestingly, complexity in PBMCs increased during
treatment (Fig. 3, 5 months), and that increment corresponded
to diversifying PBMC variants in Com 3 that were closely related to
previous PBMC-speciﬁc clusters at 0 and 3 months, which were
poorly represented in plasma before that moment. This dynamic
pattern of compartmentalization suggests that those lineages in
Com 3 detected in PBMCs at the beginning of follow-up were
somehow “naturally resistant” to α-IFN treatment and served as a
viral pool, ﬁlling the plasma compartment temporarily during
treatment.
Finally, taken together our results support the notion of a
community-based structure of the viral populations circulating
within an infected host during chronic infection and point out a
role of the PBMC compartment in the persistence of such struc-
ture. The relevance of the use of new evolutionary models to
evaluate HCV chronic infection in the context of population
structure has been recently highlighted (Gray et al., 2012). This
kind of analyses permits the identiﬁcation of independent lineages
co-evolving in an infected host for long periods, which enable to
clarify why lineages that remain unobserved for several years do
not go extinct before later reappearing. By means of these
approaches, our results highlight the signiﬁcant role of compart-
mentalization in the maintenance of chronicity during pediatric
HCV infection.
Materials and methods
Ethics statement
A written informed consent was obtained from all participants'
parents. The study protocol conforms to the ethical guidelines of
the 1975 Declaration of Helsinki as reﬂected in a priori approval by
the Ricardo Gutierrez Children's Hospital Bioethics and Research
Committees.
Subjects and samples
This retrospective study was conducted on 6 pediatric patients
with chronic HCV infection. No patient was co-infected with
HBV or HIV. Some patients were enrolled before HCV interferon
treatment was widely applied to all infected children, so only 3/6
patients received alpha interferon (α-IFN, 3MU subcutaneously,
3 times a week), which was withdrawn after at least 6 months due
to lack of response. Serum alanine aminotransferase (ALT) levels
and HCV viral load in plasma were taken from clinical records.
Formalin-ﬁxed and parafﬁn-embedded (FFPE) liver sections were
obtained from the ﬁles of our hospital's Pathology Division.
Multiple consecutive blood samples (3–5 ml) were taken from
each patient by vein puncture between years 1999 and 2010.
Plasma was immediately separated and stored at –80 1C. PBMCs
(mean number 5.3010672.69106 cells) were isolated by
centrifugation on Histopaques (SIGMA), followed by two washes
with sterile phosphate-buffered saline (PBS) 1 . Cells were ﬁnally
resuspended in sterile PBS 1 and stored at –80 1C. The super-
natants of the washing steps were aliquoted and frozen at –80 1C.
Liver samples histology
Inﬂammatory activity and ﬁbrosis were assessed in FFPE liver
sections using the modiﬁed Knodell scoring system (Histological
Activity Index, HAI) and METAVIR (Theise et al., 2007). According
to HAI, each biopsy specimen was categorized as minimal (r3),
mild (Op De Beeck et al., 2001; Bartosch and Cosset, 2006; Smith,
1999), moderate (Shimizu et al., 1996; Farci et al., 1996; Penin
et al., 2001; Bartosch et al., 2005, 2003; Roccasecca et al., 2003) or
severe hepatitis (412).
Reverse transcription (RT) and PCR ampliﬁcation
RNA was extracted from 200 ml plasma and PBMCs with Trizol
reagent (Invitrogen). RNA was denaturated at 701 C for 5 min, and
a 351 bp fragment encompassing HVR1 was ampliﬁed by RT-
nested PCR as previously described (Gismondi et al., 2009). To
rule out contamination of PBMCs with plasma-derived sequences,
supernatants from both washing steps during PBMC isolation were
tested for HCV RNA by means of a more sensitive ampliﬁcation
reaction of HCV 5'UTR (Gismondi et al., 2004).
Cloning of PCR products and sequencing
Puriﬁed PCR products were subjected to the addition of 3'A-
overhangs using Taq DNA polymerase (Invitrogen), cloned in a
pCR2.1 vector (Invitrogen) and transformed into Escherichia coli
DH5α-competent cells. Plasmid DNA from transformants produ-
cing white colonies was extracted from minipreps cultured over-
night by alkaline lysis (Sambrook and Russell, 2001). Puriﬁed
recombinant plasmid DNA was sequenced bidirectionally in an
Automated 3700 DNA Analyzer (Applied Biosystems, Foster City/
CA/USA) using the ABI PRISMs BigDye Terminator Cycle Sequen-
cing Ready Reaction Kit (Applied Biosystems).
Sequence analysis
Nucleotide sequences corresponding to all samples from each
patient were aligned using CLUSTALX program (Thompson et al.,
1997). All analysis listed below were performed from nucleotide
alignments (300 bp), which correspond to clonal sequences
encompassing HVR1 and excluding oligonucleotide sequences.
A total number of 597 clones were analyzed, of which 370 were
derived from plasma and 227 from PBMCs.
a. Quasispecies complexity. Global sequence variability at the
nucleotide level was estimated from multiple alignments of all
plasma or PBMCs-derived sequences using Shannon's entropy
S¼–∑i(piln pi), where pi is the frequency at which a given
residue is found at position i. Genetic complexity (number of
different variants within each sample) in plasma and PBMCs
was calculated with HVR1 amino acid sequences and expressed
as normalized S (SN), being SN¼S/ln N, where N is the total
number of clones in each sample. In this case, pi is the
frequency of each clone in the quasispecies. SN theoretically
varies from 0 (only one variant detected) to 1 (maximum
quasispecies complexity).
b. Phylogenetic analysis. (i) Maximum likelihood (ML) trees.
Phylogenetic analysis was performed with PhyML program
version 3.0 (Guindon and Gascuel, 2003). The most appropriate
model of evolution for each multiple alignment was inferred
using Akaike's information criterion, as implemented in
jModeltest v.0.1.1 (Posada, 2008) (Supplementary Table 1). ML
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trees were constructed by a heuristic search with the pre-
viously selected model of substitution. Bootstrap analysis (1000
pseudoreplicates) was performed on each ML tree. (ii) Networks.
Phylogenetic reconstruction was assessed through a maximum-
parsimony based heuristic algorithm implemented in Network
1.6.1.0 program using the median-joining method (Bandelt et al.,
1999). The resulting multitude of plausible trees is expressed as a
network which displays alternative potential evolutionary paths
in the form of cycles.
c. Population studies. The model-based Bayesian clustering
approach implemented in BAPS program version 5.4 (Corander
et al., 2008) was used to estimate the number of genetically
homogeneous clusters or populations. The prior for the max-
imum number of clusters (parameter K) was set between 1 and
20. Five independent runs for each dataset were performed, and
all the partitions obtained had a posterior probability greater
than 0.9.
d. Compartmentalization of viral sequences. The association
between phylogeny and compartmentalization was statistically
assessed in a Bayesian framework implemented in BaTS pro-
gram (Parker et al., 2008), which takes into account the
phylogenetic uncertainty in the analysis. The input trees were
obtained using BEAST software version 1.6.2 (Drummond and
Rambaut, 2007). All Monte Carlo Markov Chains (MCMC) were
run for 5107 generations in order to achieve an effective
sample size (ESS)4200. The substitution rate parameter was
estimated by MCMC analysis, which was run under two
molecular clock models: Strict and Relaxed Uncorrelated Log-
normal. The best clock model was selected by Bayes Factor. For
BaTS analysis, two states were deﬁned according to the
compartment from which the sequences were obtained
(plasma or PBMCs) in order to calculate three compartmenta-
lization indexes: Parsimony Score (PS), Association Index (AI)
and Monophyletic Clade (MC). The expected value of the
indexes under the non-association hypothesis was estimated
by 500 randomized sets.
e. Selection analysis. Individual codons under positive or nega-
tive selection were detected through an integrative analysis
taking into account the results of four different selection
methods (SLAC, FEL, REL and MEME) implemented in the
DataMonkey webserver (Delport et al., 2010; Kosakovsky
Pond, 2005; Murrell et al., 2012). The best-ﬁtting model of
nucleotide substitution was used. An alpha value of 0.05 was
used to assess signiﬁcance, and selection was considered when
at least two methods matched a signiﬁcant result.
Nucleotide sequence accession numbers
The GenBank/EMBL/DDBJ accession numbers of the sequences
determined in this work are EU0498394 to EU498673, KC175915
to KC176072, EU045934 to EU046001, and KF570031 to KF570102.
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